NovaBay Acquires Skincare-Focused Firm For $15M

Comments
Loading...
  • NovaBay Pharmaceuticals Inc NBY has agreed to acquire DERMAdoctor LLC, a privately-held company that commercializes dermatologist-developed skincare products, for $15.0 million.
  • The deal value includes $12.0 million in cash and an additional $3 million in earnout payments contingent upon the DERMAdoctor business achieving predetermined financial targets for the 2022 and the 2023 fiscal years.
  • DERMAdoctor produces and sells more than 30 products under brands including Ain't Misbehavin', Calm Cool + Corrected, Kakadu C, KP Duty, and Wrinkle Revenge. 
  • The acquisition has the potential to double topline revenue in 2022.
  • DERMAdoctor sells its products through major retailers.
  • The transaction will close in Q4 of 2021.
  • Price Action: NBY stock is up 7.57% at $0.69 during the market session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!